Isavuconazole
From Wikipedia, the free encyclopedia
Isavuconazole
|
|
Systematic (IUPAC) name | |
4-[2-[(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C22H17F2N5OS |
Mol. mass | 437.47 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Isavuconazole is a triazole antifungal currently in Phase III clinical trials.
|